A STUDY ON DUCHENNE MUSCULAR DYSTROPHY: CLINICAL FEATURES AND DISEASE PROGRESSION

Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by progressive muscle weakness and degeneration, primarily affecting boys. It is caused by mutations in the dystrophin gene. DMD leads to loss of muscle function, respiratory and cardiac complications, and reduced life expectancy. It primarily affects boys and usually appears in early childhood. Symptoms include difficulty walking, frequent falls, and heart and respiratory problems. Although there is no cure, treatments such as corticosteroids, gene therapy, and physiotherapy can slow disease progression and improve quality of life. Current management focuses on slowing disease progression, managing symptoms, and improving quality of life. On-going research explores innovative treatments and potential cures.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-02-14
DOI
https://doi.org/10.5281/zenodo.18638976
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A STUDY ON DUCHENNE MUSCULAR DYSTROPHY: CLINICAL FEATURES AND DISEASE PROGRESSION

Kumutha K., Suga priya R., Priyadharshini K., Preetha S. et al.
Zenodo (CERN European Organization for Nuclear Research)
Muscle Physiology and Disorders
article

A STUDY ON DUCHENNE MUSCULAR DYSTROPHY: CLINICAL FEATURES AND DISEASE PROGRESSION

Kumutha K., Suga priya R., Priyadharshini K., Preetha S., Monika K. Senthilraja M.
article en

Abstract

Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by progressive muscle weakness and degeneration, primarily affecting boys. It is caused by mutations in the dystrophin gene. DMD leads to loss of muscle function, respiratory and cardiac complications, and reduced life expectancy. It primarily affects boys and usually appears in early childhood. Symptoms include difficulty walking, frequent falls, and heart and respiratory problems. Although there is no cure, treatments such as corticosteroids, gene therapy, and physiotherapy can slow disease progression and improve quality of life. Current management focuses on slowing disease progression, managing symptoms, and improving quality of life. On-going research explores innovative treatments and potential cures.

Zenodo (CERN European Organization for Nuclear Research)
Shree Krishna Hospital (IN)
Openalex Percentile: Top 56%
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A STUDY ON DUCHENNE MUSCULAR DYSTROPHY: CLINICAL FEATURES AND DISEASE PROGRESSION — Kumutha K., Suga priya R., et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS